Clinical Trial on the Efficacy of Different Masks With and Without a Peripheral Sealing Device, Against Covid-19
NCT05079308 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 210
Last updated 2021-10-26
Summary
A significant number of professionals subjected to high-risk situations have been infected by Covid-19, due to the lack of adequate respiratory protection equipment or poor marginal sealing adjustments. Then, the objective of this study is to determine if there are statistically significant differences in the level of respiratory protection of type IIR surgical face masks and filtering face masks, used with and without a peripheral sealing device, against the contagion of Covid-19 or other harmful biological agents. The proposed device is a thermoplastic resin ring composed of a reusable and biodegradable polylactic acid designed to be used in a healthcare environment. The individuals of the study will be submitted to qualitative fit tests, that meet current Ocupational Security and Health Administration (OSHA) standard. The mentioned qualitative fit test uses a sodium saccharin solution to evaluate the respiratory protection equipment in professionals in hospitals, emergency centers, and early childhood education centers.
Conditions
- Covid19
- Personal Protective Equipment
Interventions
- DEVICE
-
Peripheral sealing device for surgical mask or filtering face piece
The individuals used a Peripheral Sealing Device on a surgical mask or a filtering face piece mask and were submitted to a qualitative fit test, regulated by the Occupational Security and Health Administration (USA).
- DEVICE
-
IIR Surgical mask with Filtering face piece
The individuals used a IIR surgical mask with a filtering face piece mask and were submitted to a qualitative fit test, regulated by the Occupational Security and Health Administration (USA).
Sponsors & Collaborators
-
University of the Balearic Islands
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-03-01
- Primary Completion
- 2021-06-30
- Completion
- 2021-08-31
Countries
- Spain
Study Locations
More Related Trials
-
Bioaerosol Sampling Device (BSD) Clinical Study
NCT06047067 ·Status: UNKNOWN
-
Clinical Trial to Evaluate the Effectiveness and Safety of Tocilizumab for Treating Patients With COVID-19 Pneumonia
NCT04445272 ·Status: COMPLETED ·Phase: PHASE2
-
Pirfenidone Compared to Placebo in Post-COVID19 Pulmonary Fibrosis COVID-19
NCT04607928 ·Status: UNKNOWN ·Phase: PHASE2
-
Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa Infection
NCT05616221 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Efficacy and PK/PD of POL7080 in Patients With Exacerbation of Non-cystic Fibrosis Bronchiectasis.
NCT02096315 ·Status: TERMINATED ·Phase: PHASE2
-
A Clinical Trial to Evaluate the Efficacy and Safety of YMC026 in Respiratory Disease Patients
NCT03334916 ·Status: COMPLETED ·Phase: PHASE4
-
Inhaled Corticosteroid Treatment of COVID19 Patients With Pneumonia
NCT04355637 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluate the Efficacy and Safety of TF0023 in Treatments for COVID-19 in Hospitalized Adults
NCT05212818 ·Status: TERMINATED ·Phase: PHASE2
-
Evaluation of the Effect of PUR118 on Ozone Induced Airway Inflammation in Healthy Normal Volunteers
NCT01690949 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of SM04646 Inhalation Solution in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
NCT03591926 ·Status: WITHDRAWN ·Phase: PHASE2
-
Efficacy of Breathox Device Inhalation Therapy in the Treatment of Acute Symptoms Associated With COVID-19 and in the Prevention of the Use of Health Resources
NCT05196581 ·Status: COMPLETED ·Phase: PHASE2
-
A Study To Determine Effects Of Fluticasone Propionate On Sputum Neutrophils After Inhaled Lipopolysaccharide Challenge In Volunteers
NCT01364519 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluate the Efficacy and Safety of FB2001 for Inhalation in Patients With Mild to Moderate COVID-19
NCT05675072 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Outcomes of Once-Daily ICS/LABA/LAMA + PRN Respiratory Therapy Treatments in Hospitalized Patients With COPD Exacerbations
NCT05292053 ·Status: COMPLETED ·Phase: PHASE4
-
Checkpoint Blockade in COVID-19 Pandemic
NCT04335305 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD
NCT06981078 ·Status: RECRUITING ·Phase: PHASE2
-
GKT137831 in IPF Patients With Idiopathic Pulmonary Fibrosis
NCT03865927 ·Status: COMPLETED ·Phase: PHASE2
-
The Use of PUL-042 Inhalation Solution to Reduce the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection
NCT04312997 ·Status: COMPLETED ·Phase: PHASE2
-
Retrospective Evaluation of Lung Pathology in Subjects With COVID-19
NCT04878913 ·Status: COMPLETED
-
To Evaluate the Safety and Efficacy of Inhaled CT-P63 and CT-P66 Combination Therapy in Symptomatic Patients With COVID-19 Not Requiring Supplemental Oxygen
NCT05224856 ·Status: WITHDRAWN ·Phase: PHASE3
-
Testing the Efficacy and Safety of BIO101 for the Prevention of Respiratory Deterioration in COVID-19 Patients
NCT04472728 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
The Use PUL-042 to Reduce the Infection Rate and Progression to COVID-19 in Adults Exposed to SARS-CoV-2
NCT04313023 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Test the Efficacy and Safety of Inhaled GB0139 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
NCT03832946 ·Status: COMPLETED ·Phase: PHASE2
-
Ph 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aeruginosa Lung Infections and Cystic Fibrosis
NCT04596319 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Nebulised RESP30X Nitric Oxide Formulations in NCFB Patients With Pseudomonas Aeruginosa (Pa)
NCT06663176 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2